spacer
home > ict > spring 2006 > calling all innovators
PUBLICATIONS
International Clinical Trials

Calling all Innovators

Intelligent interpretation of regulations can breed confidence and bring innovation back to pharma, says Ian Leake of BearingPoint

The pharmaceutical industry is being challenged like never before. Increasing regulation, globalisation, and the neverending search for blockbusters have all contributed to spiralling costs. Yet greater public oversight of healthcare costs is making it harder for the industry to maintain its traditional profitability.

Industry executives have responded in several ways: consolidation (mergers and acquisitions), searching for lower cost locations (globalisation), and demands to make sweeping cuts to departmental budgets – in some cases as much as 30 per cent from year to year. But all of this activity requires flexibility and promotes change, and if there’s one thing that the industry has learnt over the years it’s that change invites risk. And this heavily regulated industry is extremely risk averse.

A major contributor to the risk averse culture in the industry is the traditional approach to regulatory compliance (socalled ‘old compliance’). Overlapping and sometimes conflicting global and local regulations, accepted and rarely challenged ‘best practices,’ and personal interpretations have created a complex and expensive web of policies and procedures that make change costly, painful, and tiresome. The biggest casualty of this has been innovation. In all areas of operation – from clinical trials to manufacturing to finance – it is just too hard to innovate: it’s easier and safer to just keep doing the same thing, even if it’s unsustainably slow and expensive.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ian Leake is a Senior Manager in BearingPoint’s Global Life Sciences Practice, and has 14 years’ experience in the pharmaceutical industry. He has extensive expertise in leading R&D, regulatory compliance and systems integration projects and programmes. Ian currently leads BearingPoint’s Regulatory Compliance Team in the UK.
spacer
Ian Leake
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement